Home/ Stocks/ IMA

ImageneBio, Inc. Common Stock

IMA XNAS

$5.29 -0.60 (-10.17%) ▼ 15-min delayed

Open

$5.68

High

$5.90

Low

$5.28

Volume

75.4K

Market Cap

$59.67M

About ImageneBio, Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 15 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$800.0K	$-45,349,000	$-9.64
FY 2025	$800.0K	$-45,349,000	$-9.64
Q3 2025	$0	$-24,779,000	$-2.91
Q2 2010	$522.96M	$-2,011,000	$-0.10

Related Market News

No specific coverage for IMA yet. Check out our latest market news or earnings calendar.

Get IMA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ImageneBio, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.